| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 04/06/2011 | CN101601709B Water and fire empyrosis repair liquid and preparation method |
| 04/06/2011 | CN101596204B Compound fluconazole ointment and preparation method thereof |
| 04/06/2011 | CN101569634B 抗老化剂 Anti-aging agents |
| 04/06/2011 | CN101549095B Chinese medicinal composition for growing hair and blacking hair |
| 04/06/2011 | CN101513460B Traditional Chinese medicine for curing alopecia |
| 04/06/2011 | CN101468000B Application of bulleyaconitine A in preparing medicament for treating primary erythermalgia |
| 04/06/2011 | CN101451124B Preparation of human umbilical cord mesenchymal stem cells wound surface smearing agent and storage application method |
| 04/06/2011 | CN101396454B Traditional Chinese medicine for treating diabetic skin pruritus |
| 04/06/2011 | CN101361951B Skin external preparation with anti-inflammation, itching-relieving and disinfection and sterilization function and preparation method thereof |
| 04/06/2011 | CN101361776B Scald ointment |
| 04/06/2011 | CN101347617B Refined polyvalent anti-snake poison lyophilized blood serum and using method |
| 04/06/2011 | CN101336932B Freezing powder prepared from low passage pig dermal papilla cells supernatant |
| 04/06/2011 | CN101327264B Medicament for treating leukoderma and preparation method thereof |
| 04/06/2011 | CN101293894B Preparing intermediate of 2-propylidene-19-nor-vitamin D compounds |
| 04/06/2011 | CN101288679B Dissolving and reducing generation method of nano pearl powder |
| 04/06/2011 | CN101229336B External used medicine for treating chronic eczema |
| 04/06/2011 | CN101167873B Technology for processing honey-prepared glutinous rehmannia |
| 04/06/2011 | CN101152164B Anti-cicatrix externally used pad pasting containing anti-hypertrophy cell medicament and method for preparing the same |
| 04/06/2011 | CN101049374B Oral liquid for treating leucoderma, and preparation method |
| 04/06/2011 | CN100998806B Chinese medicinal decoction for treating wart |
| 04/06/2011 | CN100998604B Traditional Chinese medicine for treat burns and scald and its preparing method |
| 04/05/2011 | US7919513 Inhibitors of p38 |
| 04/05/2011 | US7919474 Gene expression inhibition; sustained release; for reduction of neuronal cell death, inflammation, and scar formation; improves wound healing, skin rejuvenation and thickening |
| 04/05/2011 | US7919085 Using secretory carrier membrane protein 5 protein specific monoclonal antibody as diagnostic tool in screening for cutaneous t-cell lymphomas (CTCL) |
| 04/05/2011 | CA2526538C Aqueous compositions for disinfection and/or sterilization |
| 04/05/2011 | CA2494695C 2-(3-aminoaryl)amino-4-aryl-thiazoles and their use as c-kit inhibitors |
| 04/05/2011 | CA2466170C Hexa-, hepta-, and octapeptides having antiangiogenic activity |
| 04/05/2011 | CA2437788C Inflammation-inhibiting compounds |
| 04/05/2011 | CA2408747C Heterocyclic inhibitors of glycogen synthase kinase gsk-3 |
| 04/02/2011 | CA2716231A1 Benzoyl peroxide composition for treating skin |
| 04/02/2011 | CA2680502A1 Benzoyl free formula (bff) acne treatment solution |
| 03/31/2011 | WO2011038417A2 Methods to accelerate tissue and wound healing rates and reduce swelling and scar formation |
| 03/31/2011 | WO2011036895A1 Maleic acid salt and crystal thereof |
| 03/31/2011 | WO2011036786A1 Stress-alleviating agent comprising plant-derived polyamine-containing extract as active ingredient |
| 03/31/2011 | WO2011036304A1 Leaven-based mixture |
| 03/31/2011 | WO2011009757A3 Use of human beta-defensin to influence the natural pigmentation process |
| 03/31/2011 | WO2010147440A3 Health food or pharmaceutical composition comprising chestnut shell extract |
| 03/31/2011 | WO2010132882A3 Sublingual dexmedetomidine compositions and methods of use thereof |
| 03/31/2011 | WO2010129313A3 Cosmetic compositions comprising cyanodiphenylacrylates |
| 03/31/2011 | WO2010117241A3 Composition for prevention or treatment of hypertrophic scars or keloids |
| 03/31/2011 | US20110077737 Tunably Crosslinked Polysaccharide Compositions |
| 03/31/2011 | US20110077309 Humectant composition |
| 03/31/2011 | US20110077298 Retinoid Derivative and Pharmaceutical Composition and Use Thereof |
| 03/31/2011 | US20110077297 Compositions and methods for treatment of inflammation and hyperkeratotic lesions |
| 03/31/2011 | US20110077288 Pharmaceutical Compositions for Treatment of MicroRNA Related Diseases |
| 03/31/2011 | US20110077264 Derivatives of 5-pyridinyl-1-azabicyclo[3.2.1]octane, preparation method thereof and use of same in therapeutics |
| 03/31/2011 | US20110077259 Compositions and methods for treating and preventing dermatoses |
| 03/31/2011 | US20110077249 1,2,4-triazolylaminoaryl (heteroaryl) sulfonamide derivatives |
| 03/31/2011 | US20110077243 Triazolopyridine Compounds Useful As Kinase Inhibitors |
| 03/31/2011 | US20110077236 New carboxylic acid amides, the preparation thereof and their use as medicaments |
| 03/31/2011 | US20110077218 Wound-healing pharmaceutical compositions in the form of a sterile powder based on amino acids and sodium hyaluronate |
| 03/31/2011 | US20110077210 Hdac regulation assays, compounds and therapeutic compositions |
| 03/31/2011 | US20110077198 Compositions and methods for inhibiting the activation of dsrna-dependent protein kinase and tumor growth inhibition |
| 03/31/2011 | US20110077194 Method for Treating or Preventing a Functional Vitamin B12 Deficiency in an Individual and to Medical Compositions for Use in Said Method |
| 03/31/2011 | US20110077193 Artemisinin Derivatives with Natural Amino Acids, Peptides, and Amino Sugars for the Treatment of Infection and Topical Condition in Mammals |
| 03/31/2011 | US20110077190 Selective Caspase Inhibitors and Uses Thereof |
| 03/31/2011 | US20110076348 Prophylactic and/or therapeutic agent for atopic dermatitis |
| 03/31/2011 | US20110076344 Use of a chemically-stabilized chlorite solution for inhibiting an antigen-specific immune response |
| 03/31/2011 | US20110076331 Use of Deuterium Oxide as an Elastase Inhibitor |
| 03/31/2011 | US20110076329 Graft prosthesis, material and methods |
| 03/31/2011 | US20110076328 Compositions for the treatment of hair loss |
| 03/31/2011 | US20110076321 Self-adhesive polymer matrix containing sea algae extract |
| 03/31/2011 | US20110076311 Ceramide dispersion |
| 03/31/2011 | US20110076303 Methods for Screening for Anti-Graying Agents on the Basis of AFF-4 |
| 03/31/2011 | US20110076295 Lactoferrin in the treatment of malignant neoplasms and other hyperproliferative diseases |
| 03/31/2011 | US20110076293 Triptolide derivatives for modulation of apoptosis and immunosuppression |
| 03/31/2011 | US20110076279 Fully human anti-vegf antibodies and methods of using |
| 03/31/2011 | US20110076244 Surface coatings for skin |
| 03/31/2011 | US20110076243 Modified hydrophilic polymers containing hydrophobic groups |
| 03/31/2011 | CA2775027A1 Maleic acid salt and crystal thereof |
| 03/30/2011 | EP2302035A2 A method of producing a cultured skin device |
| 03/30/2011 | EP2301971A1 Antibodies that bind both BCMA and TACI |
| 03/30/2011 | EP2301970A1 Human antibodies that bind human IL-12 and methods for producing |
| 03/30/2011 | EP2301969A1 IL-31 monoclonal antibodies and methods of use |
| 03/30/2011 | EP2301915A1 7-(diethylamino)methyl substituted tetracycline having target therapeutic activities |
| 03/30/2011 | EP2301629A2 Anti-interferon-alpha antibodies |
| 03/30/2011 | EP2301578A2 Methods for treating TWEAK-related conditions |
| 03/30/2011 | EP2301577A2 Methods for treating TWEAK-related conditions |
| 03/30/2011 | EP2301562A1 Irrigation solution and method for inhibition of pain, inflammation and spasm |
| 03/30/2011 | EP2301560A1 Pharmaceutical agent for promoting the functional regeneration of damaged tissue |
| 03/30/2011 | EP2301559A1 Agent for recruitment of bone-marrow-derived pluripotent stem cell into peripheral circulation |
| 03/30/2011 | EP2301558A1 Preventative and/or therapeutic agent against atopic dermatitis |
| 03/30/2011 | EP2301550A1 Tetracycline compounds having target therapeutic activities |
| 03/30/2011 | EP2301547A1 Use of activators of soluble guanylate cyclase for improving wound healing |
| 03/30/2011 | EP2301534A1 Amino-methyl substituted tetracycline compounds |
| 03/30/2011 | EP2301362A1 Mixture on the basis of a sourdough |
| 03/30/2011 | EP2301343A1 Embryonic-like stem cells derived from post-partum mammalian placenta and uses and methods of treatment using said cells |
| 03/30/2011 | EP2300604A1 Nitric oxide compositions and devices and methods for cosmesis |
| 03/30/2011 | EP2300603A1 Nitric oxide device and method for wound healing, treatment of dermatological disorders and microbial infections |
| 03/30/2011 | EP2300439A1 Therapeutic substituted hydantoins, and related compounds |
| 03/30/2011 | EP2300043A1 Analgesic effects of peptide toxin apetx2 |
| 03/30/2011 | EP2300003A2 Methods for treating injury associated with exposure to an alkylating species |
| 03/30/2011 | EP2299972A1 Topical compositions |
| 03/30/2011 | EP2299815A1 Method of treating burns using avermectin compound |
| 03/30/2011 | EP2299810A1 Topical pharmaceutical formulations containing a low concentration of benzoyl peroxide in suspension in water and a water-miscible organic solvent |
| 03/30/2011 | EP1843789B1 Compositions and methods for treating fibrotic disorders |
| 03/30/2011 | EP1807083B1 Use of pirlindole for the treatment of diseases which are characterized by proliferation of t-lymphocytes and/or hyperproliferation of keratinocytes in particular atopic dermatitis and psoriasis |
| 03/30/2011 | EP1775289B1 Novel imidazolidine derivatives |
| 03/30/2011 | EP1622579B1 Cosmetic compositions and methods for using same to improve the aesthetic appearance of skin |
| 03/30/2011 | EP1503773B1 Hepatoprotective activity of 2 -p-hydroxybenzoylmussaenosidic acid |